Gliftor is produced commercially through a straightforward synthetic route. The process begins with the preparation of the substituted aniline precursor, which is reacted with fluoroacetyl chloride under controlled conditions to introduce the fluoroacetyl group. This acylation step yields the active gliftor molecule, which is then purified by recrystallisation or solvent extraction to remove residual reactants and by products.
poison by ingestion, inhalation, and skin
contact. An eye irritant
Metabolic action distrupts the citric acid cycle
